Clinical Trial Update: A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Covigenix VAX-001, a prophylactic plasmid DNA vaccine for SARS-CoV-2, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Disease

Drugs mentioned

• Covigenix VAX-001

Snippet

Sponsor: Entos Pharmaceuticals Inc. | Conditions: SARS-CoV-2 | Phase 1, Phase 2 | Status: COMPLETED